ENTITY

Syros Pharmaceuticals (SYRS US)

Analysis

Health Care • United States

Syros Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company focuses on developing treatments for cancer and immune-mediated diseases, as well as building a pipeline of gene control medicines. Syros Pharmaceuticals conducts business worldwide.

Refresh

Focused

No publications yet

There aren’t any syndicated reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00